AG
ARLZ

Advisor Group’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Advisor Group’s Portfolio ARLZ Stock Details ARLZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-3,820
Closed -$1K – 5426
2018
Q2 		$1K Sell
3,820
-2,200
-37% -$1.8K ﹤0.01% 4900
2018
Q1 		$9K Hold
6,020
– – ﹤0.01% 4187
2017
Q4 		$9K Sell
6,020
-2,240
-27% -$3.68K ﹤0.01% 4183
2017
Q3 		$19K Sell
8,260
-30,090
-78% -$40.3K ﹤0.01% 3603
2017
Q2 		$52K Sell
38,350
-32,577
-46% -$47.1K ﹤0.01% 2832
2017
Q1 		$151K Sell
70,927
-34,076
-32% -$128K ﹤0.01% 1865
2016
Q4 		$463K Sell
105,003
-10,181
-9% -$48.3K 0.01% 1064
2016
Q3 		$559K Buy
115,184
+78,984
+218% +$360K 0.01% 917
2016
Q2 		$118K Buy
+36,200
New +$137K ﹤0.01% 1811

Other funds holding ARLZ

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Advisor Group's ARLZ Position: Q3 2018 in Review

Advisor Group sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q3 2018, closing a stake of 3,820 shares — an estimated $1K sold.

Advisor Group first reported a position in ARLZ in Q2 2016 and held it in 9 quarters. The position peaked at $559K in Q3 2016. 4 funds tracked by Wall St. Rank hold ARLZ as of Q3 2018.

  • Advisor Group reported no remaining Aralez Pharmaceuticals Inc. position as of Q3 2018 after selling out during the quarter.
  • Advisor Group sold 3,820 Aralez Pharmaceuticals Inc. shares in Q3 2018, an estimated $1K.
  • Advisor Group first reported a position in Aralez Pharmaceuticals Inc. in Q2 2016 and held it in 9 quarters.
  • Advisor Group's Aralez Pharmaceuticals Inc. position peaked at $559K in Q3 2016.
  • 4 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q3 2018.

Based on Advisor Group's 13F filing for Q3 2018, filed 14 Nov 2018.